Anticoagulants in Venous Thromboembolism

REFERENCES

• Paraskos JA, Adelstein SJ, Smith RE, et al: Late prognosis of acute pulmonary embolism. N Engl J Med 289:55, 1973
   PubMed Web of Science ®Google Scholar
• Tow DE, Wagner HN Jr: Recovery of pulmonary arterial blood flow in patients with pulmonary embolism. N Engl J Med 276:1053, 1967
   PubMed Web of Science ®Google Scholar
• Walker RH, Jackson JA: Resolution of pulmonary embolism. Br Med J 4:135, 1970
   PubMedGoogle Scholar
• Chait A, Summers D, Krasnow N, et al: Observations on the fate of large pulmonary emboli. Am J Roentgenol Radium Ther Nucl Med 100:364, 1967
   PubMedGoogle Scholar
• Sevitt S, Gallagher NG: Prevention of venous thrombosis and pulmonary embolism in injured patients. Lancet 2:981, 1959
   PubMed Web of Science ®Google Scholar
• Barritt DW, Jordan SC: Anticoagulant drugs in the treatment of pulmonary embolism. Lancet 1:1309, 1960
   PubMed Web of Science ®Google Scholar
• Basu D, Gallus A, Hirsh J, et al: A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N Engl J Med 287:324, 1972
   PubMed Web of Science ®Google Scholar
• Douglas AS: Anticoagulant Therapy. Oxford, England, Blackwell Scientific Publications, 1962
   Google Scholar
• Yin ET, Wessler S, Stoll PJ: Identity of plasma-activated factor X inhibitor with antithrombin III and heparin cofactor. J Biol Chem 246:3712–3719, 10 Jun 1971
   PubMedGoogle Scholar
• Estes JW: The kinetics of heparin. Ann NY Acad Sci 179:187, 1971
   PubMed Web of Science ®Google Scholar
• Deykin D, Wessler S, Reimer SM: Evidence for an antithrombotic effect of Dicumarol. Am J Physiol 199:1161, 1960
   PubMed Web of Science ®Google Scholar
• Murray G: Anticoagulants in venous thrombosis and the prevention of pulmonary embolism. Surg Gynecol Obstet 84:665, 1947
   PubMedGoogle Scholar
• Eika C, Godal HC, Kierulf P: Detection of small amounts of heparin by the thrombin clotting-time. Lancet 2:376, 1972
   PubMed Web of Science ®Google Scholar
• Hume M, Sevitt S, Thomas DP: Venous Thrombosis and Pulmonary Embolism. Cambridge, Mass, Harvard University Press, 1970
   Google Scholar
• Donaldson GA, Williams C, Scannell JG, et al: A reappraisal of the application of the Trendelenburg operation to massive fatal embolism. N Engl J Med 268:171, 1963
   PubMed Web of Science ®Google Scholar
• Salzman EW, Harris WH, DeSanctis RW: Anticoagulation for prevention of thromboembolism following fractures of the hip. N Engl J Med 275: 122, 1966
   PubMed Web of Science ®Google Scholar
• Kakkar W, Corrigan T, Spindler J, et al: EflScacy of low doses of heparin in prevention of deep-vein thrombosis after major surgery. A double-blind, randomised study. Lancet 2:101, 1972
   PubMed Web of Science ®Google Scholar
• Nicolaides AN, Dupont PA, Desai S, et al: Small doses of subcutaneous sodium heparin in preventing deep venous thrombosis after major surgery. Lancet 2:890, 1972
   PubMed Web of Science ®Google Scholar
• Gallus AS, Hirsh J, Tuttle RJ, et al: Small subcutaneous doses of heparin in prevention of venous thrombosis. N Engl J Med 288:545, 1973
   PubMed Web of Science ®Google Scholar
• Sevitt S, Innes D: Prothrombin-time and thrombotest in injured patients on prophylactic anticoagulant therapy. Lancet 1:124, 1964
   PubMed Web of Science ®Google Scholar
• Sharnoff JC: Prevention of sudden cardiopulmonary arrest in the perioperative period with prophylactic heparin. Lancet 2:292, 1969
   PubMed Web of Science ®Google Scholar
• Sharnoff JG, DeBiasio G: Prevention of fatal postoperative thromboembolism by heparin prophylaxis. Lancet 2:1006, 1970
   PubMed Web of Science ®Google Scholar
• Williams HT: Prevention of postoperative deepvein thrombosis with perioperative subcutaneous heparin. Lancet 2:950, 1971
   PubMed Web of Science ®Google Scholar
• Ballard RM, Bradley-Watson PJ, Johnstone FD, et al: Low doses of subcutaneous heparin in the prevention of deep vein thrombosis after gynaecological surgery. J Obstet Gynaecol Br Commonw 80:469, 1973
   PubMedGoogle Scholar
• Handley AJ: Low-dose heparin after myocardial infarction. Lancet 2:623, 1972
   PubMed Web of Science ®Google Scholar
• Ahlberg A, Nylander G, Robertson B, et al: Dextran in prophylaxis of thrombosis in fractures of the hip. Acta Chir Scand Suppl 387:83, 1968
   PubMedGoogle Scholar
• Johnsson SR, Bygdeman S, Eliasson R: Effect of dextran on postoperative thrombosis. Acta Chir Scand Suppl 387:80, 1968
   PubMedGoogle Scholar
• Report of the working party on anticoagulant therapy in coronary thrombosis to the Medical Research Council: Assessment of short term anticoagulant administration after cardiac infarction. Br Med J 1:335, 1969
   PubMed Web of Science ®Google Scholar
• Wray R, Maurer B, Shillingford J: Prophylactic anticoagulant therapy in the prevention of calf-vein thrombosis after myocardial infarction. N Engl J Med 288:815, 1973
   PubMed Web of Science ®Google Scholar
• Rosengarten DS, Laird J: The effect of leg elevation on the incidence of deep-vein thrombosis after operation. Br J Surg 58:182, 1971
   PubMed Web of Science ®Google Scholar
• Flanc C, Kakkar W, Clarke MB: Postoperative deep-vein thrombosis. Effect of intensive prophylaxis. Lancet 1:477–478, 8 Mar 1969
   Google Scholar
• Byrne JJ: Phlebitis: A study of 979 cases at the Boston City Hospital. JAMA 174:113–118, 10 Sept 1960
   PubMed Web of Science ®Google Scholar
• Little JM, Loewenthal J, Mills FH: Venous thrombo-embolic disease. Br J Surg 53:657, 1966
   PubMed Web of Science ®Google Scholar
• Bauer G: Clinical experiences of a surgeon in the use of heparin. Am J Cardiol 14:29, 1964
   PubMed Web of Science ®Google Scholar
• Thomas DP: Treatment of pulmonary embolic disease. N Engl J Med 273:885, 1965
   PubMed Web of Science ®Google Scholar
• O'Sullivan EF, Hirsh J, McCarthy RA, et al: Heparin in the treatment of venous thromboembolic disease. Med J Aust 2:153, 1968
   PubMedGoogle Scholar
• Sibley C, Singer JW, Wood RJ: Comparison of activated partial thromboplastin time reagents. Am J Clin Pathol 59:581, 1973
   PubMed Web of Science ®Google Scholar
• Hirsh J, Gallus AS: The activated partial thromboplastin time. N Engl J Med 288:1410, 1973
   Web of Science ®Google Scholar
• Hirsh J, Cade JF, O'Sullivan EF: Clinical experience with anticoagulant therapy during pregnancy. Br Med J 1:270, 1970
   PubMed Web of Science ®Google Scholar
• Steele PP, Weily HS, Genton E: Platelet survival and adhesiveness in recurrent venous thrombosis. N Engl J Med 288:1148, 1973
   PubMed Web of Science ®Google Scholar
• Hirsh J, O'Sullivan EF, Gallus AS, et al: Evaluation of subcutaneous calcium heparin therapy in the treatment of thrombo-embolic disease. Med J Aust 1:15, 1970
   PubMed Web of Science ®Google Scholar
• Coon WW, Willis PW III: Recurrence of venous thromboembolism. Surgery 73:823, 1973
   PubMed Web of Science ®Google Scholar
• Koch-Weser J, Sellers EM: Drug interactions with coumarin anticoagulants. N Engl J Med 285:487, 1971
   Web of Science ®Google Scholar
• Jick H, Sione D, Borda IT, et al: Efficacy and toxicity of heparin in relation to age and sex. N Engl J Med 279:284, 1968
   PubMed Web of Science ®Google Scholar